Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models

NCT00271973 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain

NCT02362672 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

NCT00214955 ·Status: COMPLETED ·Phase: PHASE3

Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain

NCT05962294 ·Status: UNKNOWN

Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects

NCT01959204 ·Status: COMPLETED ·Phase: PHASE4

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain

NCT03176121 ·Status: COMPLETED ·Phase: PHASE4

Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain

NCT02824276 ·Status: COMPLETED ·Phase: PHASE1

Open Label Assessment of Long-Term Safety and Utility

NCT00904449 ·Status: COMPLETED ·Phase: PHASE3

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

NCT00549042 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

NCT00228605 ·Status: COMPLETED ·Phase: PHASE3

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

NCT05265052 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone

NCT00945919 ·Status: UNKNOWN ·Phase: NA

Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain

NCT02741076 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

NCT00365898 ·Status: TERMINATED ·Phase: PHASE3

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

NCT00485225 ·Status: COMPLETED ·Phase: PHASE2

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

NCT04218409 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Attenuation of Pain in Men and Women

NCT01220414 ·Status: COMPLETED ·Phase: NA

Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial

NCT02152592 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

NCT00390039 ·Status: COMPLETED ·Phase: PHASE3

Brain Response to Pain Control in People With Chronic Pain

NCT01878019 ·Status: COMPLETED

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

NCT00930943 ·Status: COMPLETED ·Phase: PHASE4

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects

NCT00765856 ·Status: TERMINATED ·Phase: PHASE3

Cytochrome P450's Pharmacogenomics in Chronic Pain Patients

NCT03411759 ·Status: COMPLETED

Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

NCT00105287 ·Status: COMPLETED ·Phase: PHASE3